Anuh Pharma Limited (ANUHPHR) — Financial Results | 20 May 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Anuh Pharma Limited announced audited FY2025-26 results showing cash generated from operations of ₹4,824.66 crores and net cash used in financing of ₹485.97 crores, with cash reserves declining to ₹805.97 crores. The Board recommended a ₹1.50 per share dividend (30% payout) and reappointed directors including Arun Todarwal. AGM is set for 12 August 2026, with record date on 5 August 2026. Regulatory updates include new quality leadership and auditor appointments effective August 2026.

📄 View Original Announcement (PDF)

About Anuh Pharma Limited (ANUHPHR)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹896.2 Cr P/E: 20.3 ROE: 12.5% ROCE: 17.2% Div Yield: 1.68%

View full ANUHPHR stock details →

📡 Get AI alerts when ANUHPHR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANUHPHR — Free

📊 More ANUHPHR filings

See all ANUHPHR filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANUHPHR files new disclosures

Track ANUHPHR filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANUHPHR — Free

Free account · 2 AI queries/day